Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Nasopharyngeal Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Fulvestrant 32 Specimen Handling 29 Letrozole 28 Paclitaxel 23 Carboplatin 19 ribociclib 18 pembrolizumab 18 exemestane 18 Capecitabine 17 Trastuzumab 16 palbociclib 15 Tamoxifen 15 Magnetic Resonance Spectroscopy 15 Anastrozole 15 Biopsy 13 trastuzumab deruxtecan 12 abemaciclib 12 pertuzumab 11 Radiotherapy 10 Cyclophosphamide 9 olaparib 7 inavolisib 7 elacestrant 7 Standard of Care 7 Radiation 7 Mastectomy, Segmental 7 Goserelin 7 130-nm albumin-bound paclitaxel 7 X-Rays 6 Taxes 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × camrelizumab × 30 days × Clear all

NCT05582499 2026-05-28

FASCINATE-N

Fudan University

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡